We have also included and presently extracting 20 new pharmacological and/or preventive RCTs:
ADER F, medRxiv, 2021 (DisCoVeRy trial) |
Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial |
Bundgaard H, Ann Intern Med. 2020 |
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers |
Cadegiani F, medRxiv, 2020 |
5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men. |
Cadegiani F, ResearchSquare, 2021 |
Proxalutamide (GT0918) Reduces the Rate of Hospitalization and Death in COVID-19 Male Patients: A Randomized Double-Blinded Placebo-Controlled Trial. |
Cadegiani FA, Research Square, 2020 |
Dutasteride Reduces Viral Shedding, Inflammatory Responses and Time-to-Remission in COVID-19: Biochemical Findings of a Randomized Double-Blind Placebo Controlled Interventional Trial (DUTA AndroCoV-Trial - Biochemical). |
Cohen J, Lancet Respir Med, 2021 |
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial |
Darazam I, ResearchSquare, 2021 |
Role of Interferon Therapy in Severe COVID-19: The COVIFERON Randomized Controlled Trial |
Darazam I, ResearchSquare, 2021 |
An Investigation Into the Beneficial Effects of High-Dose Interferon beta 1-a, Compared to Low-Dose Interferon Beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19 |
Elgazzar A, ResearchSquare, 2020 |
Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic |
Ghahremani M, ResearchSquare, 2021 |
Exogenous Surfactant Versus Placebo in the Treatment of Moderate and Severe ARDS in COVID-19: The Pilot Study of a Clinical Trial |
Hashim A, medRxiv, 2020 |
Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq |
Holubovska O, medRxiv, 2021 |
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial |
JamaliMoghadamSiahkali S, ResearchSquare, 2021 |
Safety and Effectiveness of High-Dose Vitamin C in Patients with COVID-19 |
Kirti R, medRxiv, 2021 |
Ivermectin as a potential treatment for mild to moderate COVID-19: A double blind randomized placebo-controlled trial |
Kumari P, Cureus, 2020 |
The Role of Vitamin C as Adjuvant Therapy in COVID-19. |
Niaee MS, Research Square, 2020, |
Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial. |
Roostaei A, ResearchSquare, 2021 |
Efficacy and Safety of Levamisole Treatment in Clinical Presentations of Patients With COVID-19: A Double-Blind, Randomized, Controlled Trial |
Sedighiyan M, Authorea, 2021 ( preprint |
Omega-3 polyunsaturated fatty acids supplementation improve clinical symptoms in patients with covid-19: A randomized clinical trial |
Shah M, Int Immunopharmacol, 2021 |
Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study). |
Torres-Zambrano GM, medRxiv, 2020 |
Renal Involvement in patients with COVID-19 Pneumonia and Outcomes after Stem Cell Nebulization |
In addition to 11 RCT evaluating Non-pharmacological interventions and long COVID treatments included and pending extraction: